Description

In this enlightening episode of The Business of Pharmacy Podcast, we delve into the intricate world of mergers and acquisitions in the biotech sector with Steve St. Onge, a seasoned expert from Paratech Pharmaceuticals. Steve shares valuable insights into the challenges and strategies of managing a single-product company in a volatile market, exploring the dynamics of both buy-side and sell-side M&As. His journey from a clinical practitioner to a corporate development leader offers a unique perspective on the biotech landscape.

https://www.paratekpharma.com/

1. [00:00:12] - Introduction of Steve St. Onge
2. [00:00:44] - Challenges for single-product companies
3. [00:02:20] - Strategic reasons behind M&As
4. [00:06:49] - Initiation of merger discussions
5. [00:10:21] - Role of relationships in M&A
6. [00:13:12] - Emotional aspects of biotech M&A
7. [00:16:14] - Clinical to corporate transition
8. [00:19:39] - Persistence in M&A success
9. [00:27:18] - Drug development and M&A impact
10. [00:35:19] - PharmD to MBA growth journey

⁠The Business of Pharmacy Podcast™⁠ offers in-depth, candid conversations with pharmacy business leaders. Hosted by pharmacist Mike Koelzer, each episode covers new topics relevant to pharmacists and pharmacy owners. Listen to a new episode every Monday morning.